Skip to main content
Top
Published in: Virology Journal 1/2013

Open Access 01-12-2013 | Research

Prevalence of active hepatitis C virus infections among general public of Lahore, Pakistan

Authors: Muhammad Ikram Anwar, Moazur Rahman, Mahmood Ul Hassan, Mazhar Iqbal

Published in: Virology Journal | Issue 1/2013

Login to get access

Abstract

Background

To find out the prevalence of active hepatitis C virus (HCV) infections among general public in Lahore city, since data concerning the prevalence of active HCV in this city is currently unavailable.

Methods

Blood samples were collected randomly from individuals visiting different clinical laboratories in Lahore. Serum was separated and processed by nested PCR qualitative assay for the detection of HCV RNA. The samples were categorized into different age groups on the basis of pre-test questionnaires in order to record the age-wise differences regarding the prevalence of active HCV. Data were analyzed statistically using Chi-Square test.

Results

Out of the 4246 blood samples analyzed in this study, 210 were confirmed to be positive for active HCV infection. Gender-wise active HCV prevalence revealed no significant difference [OR = 1.10 CI = (0.83-1.46), p > 0.05]. However, among the age groups the highest prevalence was observed in the age groups 20–29 (7.7%) and 30–39 years (6.4%) with odds of prevalence of 14.8% (OR = 2.48, CI = (1.40-4.38), p < 0.05) and 10.3% (OR = 2.03, CI = (1.10-3.71), respectively. In age groups above 40 years (40–49, 50–59 and >59 years), a decrease in levels of active HCV prevalence was observed.

Conclusions

Among tested samples, 4.9% of the subjects were confirmed to harbour active HCV infections and the “middle aged” population in Lahore was found to be at a higher risk of the HCV ailments compared to both their younger and older peers.
Appendix
Available only for authorised users
Literature
2.
go back to reference Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL: Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 1999, 29: 908-914. 10.1002/hep.510290311PubMedCrossRef Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL: Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 1999, 29: 908-914. 10.1002/hep.510290311PubMedCrossRef
5.
go back to reference Ray Kim W: Global epidemiology and burden of hepatitis C. Microbes Infect 2002, 4: 1219-1225. 10.1016/S1286-4579(02)01649-0PubMedCrossRef Ray Kim W: Global epidemiology and burden of hepatitis C. Microbes Infect 2002, 4: 1219-1225. 10.1016/S1286-4579(02)01649-0PubMedCrossRef
6.
go back to reference Waheed Y, Shafi T, Safi SZ, Qadri I: Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World J Gastroenterol 2009, 15: 5647-5653. 10.3748/wjg.15.5647PubMedPubMedCentralCrossRef Waheed Y, Shafi T, Safi SZ, Qadri I: Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World J Gastroenterol 2009, 15: 5647-5653. 10.3748/wjg.15.5647PubMedPubMedCentralCrossRef
7.
go back to reference Ali SA, Donahue RM, Qureshi H, Vermund SH: Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis 2009, 13: 9-19. 10.1016/j.ijid.2008.06.019PubMedPubMedCentralCrossRef Ali SA, Donahue RM, Qureshi H, Vermund SH: Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis 2009, 13: 9-19. 10.1016/j.ijid.2008.06.019PubMedPubMedCentralCrossRef
8.
go back to reference Raja NS, Janjua KA: Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect 2008, 41: 4-8.PubMed Raja NS, Janjua KA: Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect 2008, 41: 4-8.PubMed
9.
go back to reference Muzaffar F, Hussain I, Haroon TS: Hepatitis C: the dermatologic profile. J Pak Assoc Dermatol 2008, 18: 171-181. Muzaffar F, Hussain I, Haroon TS: Hepatitis C: the dermatologic profile. J Pak Assoc Dermatol 2008, 18: 171-181.
10.
go back to reference Masood R, Sardar MA, Mallhi AA: Seroprevalence of hepatitis B and C among the healthy blood donors at Fauji Foundation Hospital, Rawalpindi. Pak J Med Sci 2007, 23: 64-67. Masood R, Sardar MA, Mallhi AA: Seroprevalence of hepatitis B and C among the healthy blood donors at Fauji Foundation Hospital, Rawalpindi. Pak J Med Sci 2007, 23: 64-67.
11.
go back to reference Bosan A, Qureshi H, Bile KM, Ahmad I, Hafiz R: A review of hepatitis viral infections in Pakistan. J Pak Med Assoc 2010, 60: 1045-1058.PubMed Bosan A, Qureshi H, Bile KM, Ahmad I, Hafiz R: A review of hepatitis viral infections in Pakistan. J Pak Med Assoc 2010, 60: 1045-1058.PubMed
12.
go back to reference Qureshi H, Bile KM, Jooma R, Alam SE, Afridi HU: Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Mediterr Health J 2010,16(Suppl):S15-S23.PubMed Qureshi H, Bile KM, Jooma R, Alam SE, Afridi HU: Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Mediterr Health J 2010,16(Suppl):S15-S23.PubMed
13.
go back to reference Kazmi KSA, Dil AS, Zuberi SJ: Prevalence of HCV in blood donors. Pak J Med Res 1997, 36: 61-62. Kazmi KSA, Dil AS, Zuberi SJ: Prevalence of HCV in blood donors. Pak J Med Res 1997, 36: 61-62.
14.
go back to reference Khan MSA, Khalid M, Ayub N, Javed M: Seroprevalence and risk factors of hepatitis C virus (HCV) in Mardan, NWFP: a hospital based study. Rawal Med J 2004, 29: 57-60. Khan MSA, Khalid M, Ayub N, Javed M: Seroprevalence and risk factors of hepatitis C virus (HCV) in Mardan, NWFP: a hospital based study. Rawal Med J 2004, 29: 57-60.
15.
go back to reference Ali A, Ahmad H, Ali I, Khan S, Zaidi G, Idrees M: Prevalence of active hepatitis c virus infection in district mansehra pakistan. Virol J 2010, 7: 334. 10.1186/1743-422X-7-334PubMedPubMedCentralCrossRef Ali A, Ahmad H, Ali I, Khan S, Zaidi G, Idrees M: Prevalence of active hepatitis c virus infection in district mansehra pakistan. Virol J 2010, 7: 334. 10.1186/1743-422X-7-334PubMedPubMedCentralCrossRef
16.
go back to reference Muhammad N, Jan MA: Frequency of hepatitis “C” in Buner, NWFP. J Coll Physicians Surg 2005, 15: 11-14. Muhammad N, Jan MA: Frequency of hepatitis “C” in Buner, NWFP. J Coll Physicians Surg 2005, 15: 11-14.
17.
go back to reference Tariq WU, Hussain AB, Karamat KA, Ghani E, Hussain T, Hussain S: Demographic aspects of hepatitis C in northern Pakistan. J Pak Med Assoc 1999, 49: 198-201.PubMed Tariq WU, Hussain AB, Karamat KA, Ghani E, Hussain T, Hussain S: Demographic aspects of hepatitis C in northern Pakistan. J Pak Med Assoc 1999, 49: 198-201.PubMed
18.
go back to reference Akbar H, Idrees M, Manzoor S, Rehman IU, Butt S, Yousaf M, Rafique S, Awan Z, Khubaib B, Akram M: Hepatitis C virus infection: a review of the current and future aspects and concerns in Pakistan. J Gen Mol Virol 2009, 1: 12-18. Akbar H, Idrees M, Manzoor S, Rehman IU, Butt S, Yousaf M, Rafique S, Awan Z, Khubaib B, Akram M: Hepatitis C virus infection: a review of the current and future aspects and concerns in Pakistan. J Gen Mol Virol 2009, 1: 12-18.
19.
go back to reference Batool SA, Chaudhry N, Majeed K: Economic potential of recycling business in Lahore, Pakistan. Waste Manag 2008, 28: 294-298. 10.1016/j.wasman.2006.12.007PubMedCrossRef Batool SA, Chaudhry N, Majeed K: Economic potential of recycling business in Lahore, Pakistan. Waste Manag 2008, 28: 294-298. 10.1016/j.wasman.2006.12.007PubMedCrossRef
20.
go back to reference Ahmad W, Ijaz B, Javed FT, Jahan S, Shahid I, Khan FM, Hassan S: HCV genotype distribution and possible transmission risks in Lahore, Pakistan. World J Gastroenterol 2010, 16: 4321-4328. 10.3748/wjg.v16.i34.4321PubMedPubMedCentralCrossRef Ahmad W, Ijaz B, Javed FT, Jahan S, Shahid I, Khan FM, Hassan S: HCV genotype distribution and possible transmission risks in Lahore, Pakistan. World J Gastroenterol 2010, 16: 4321-4328. 10.3748/wjg.v16.i34.4321PubMedPubMedCentralCrossRef
21.
go back to reference Akhtar AM, Khan MA, Ijaz T, Iqbal Z, Rana MY, Maqbool A, Rehman A: Seroprevalence and Determinants of Hepatitis-C Virus Infection in Blood Donors of Lahore, Pakistan. Pak J Zool 2013, 45: 1-7. Akhtar AM, Khan MA, Ijaz T, Iqbal Z, Rana MY, Maqbool A, Rehman A: Seroprevalence and Determinants of Hepatitis-C Virus Infection in Blood Donors of Lahore, Pakistan. Pak J Zool 2013, 45: 1-7.
22.
go back to reference Khan H: A study of seroprevalence of hepatitis B and C in mothers and children in Lahore. Pak Pediatr J 1996, 20: 163-166. Khan H: A study of seroprevalence of hepatitis B and C in mothers and children in Lahore. Pak Pediatr J 1996, 20: 163-166.
23.
go back to reference Parker S, Khan H, Cubitt W: Detection of antibodies to hepatitis C virus in dried blood spot samples from mothers and their offspring in Lahore, Pakistan. J Clin Microbiol 1999, 37: 2061-2063.PubMedPubMedCentral Parker S, Khan H, Cubitt W: Detection of antibodies to hepatitis C virus in dried blood spot samples from mothers and their offspring in Lahore, Pakistan. J Clin Microbiol 1999, 37: 2061-2063.PubMedPubMedCentral
24.
go back to reference Aslam M, Aslam J: Seroprevalence of the antibody to hepatitis C in select groups in the Punjab region of Pakistan. J Clin Gastroenterol 2001, 33: 407-411. 10.1097/00004836-200111000-00013PubMedCrossRef Aslam M, Aslam J: Seroprevalence of the antibody to hepatitis C in select groups in the Punjab region of Pakistan. J Clin Gastroenterol 2001, 33: 407-411. 10.1097/00004836-200111000-00013PubMedCrossRef
25.
go back to reference Idrees M, Riazuddin S: Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 2008, 8: 69. 10.1186/1471-2334-8-69PubMedPubMedCentralCrossRef Idrees M, Riazuddin S: Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 2008, 8: 69. 10.1186/1471-2334-8-69PubMedPubMedCentralCrossRef
26.
go back to reference Tanveer A, Batool K, Qureshi AW: Prevalence of hepatitis B and c in university of the Punjab, Quaid-e-azam campus, Lahore. J Agric Biol Sci 2008, 3: 30-32. Tanveer A, Batool K, Qureshi AW: Prevalence of hepatitis B and c in university of the Punjab, Quaid-e-azam campus, Lahore. J Agric Biol Sci 2008, 3: 30-32.
27.
go back to reference Hyder S, Hussain W, Aslam M, Maqbool S: Seroprevalence of anti-HCV in asymptomatic children. Pak J Pathol 2001, 12: 89-93. Hyder S, Hussain W, Aslam M, Maqbool S: Seroprevalence of anti-HCV in asymptomatic children. Pak J Pathol 2001, 12: 89-93.
28.
go back to reference Zafar MMA, Husain I, Shah A: Prevalence of hepatitis C among pregnant women. J Surg Pak 2001, 6: 32-33. Zafar MMA, Husain I, Shah A: Prevalence of hepatitis C among pregnant women. J Surg Pak 2001, 6: 32-33.
29.
go back to reference Chaudry NTJW, Ihsan I, Nasreen S: Hepatitis C. Prof Med J 2005, 12: 364-367. Chaudry NTJW, Ihsan I, Nasreen S: Hepatitis C. Prof Med J 2005, 12: 364-367.
30.
go back to reference Zafar T, Ahmed MA, Strathdee SA: High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan. Harm Reduc J 2006, 3: 26. 10.1186/1477-7517-3-26CrossRef Zafar T, Ahmed MA, Strathdee SA: High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan. Harm Reduc J 2006, 3: 26. 10.1186/1477-7517-3-26CrossRef
31.
go back to reference Malik N, Hussain Z, Khan M: Markers of viral hepatitis in hemophiliacs. Biomedica 2006, 22: 48-50. Malik N, Hussain Z, Khan M: Markers of viral hepatitis in hemophiliacs. Biomedica 2006, 22: 48-50.
32.
go back to reference Afridi SQ, Zahid MN, Shabbir MZ, Hussain Z, Mukhtar N, Tipu MY, Akhtar F, Yaqub T: Prevalence of HCV genotypes in district Mardan. Virol J 2013, 10: 90. 10.1186/1743-422X-10-90PubMedPubMedCentralCrossRef Afridi SQ, Zahid MN, Shabbir MZ, Hussain Z, Mukhtar N, Tipu MY, Akhtar F, Yaqub T: Prevalence of HCV genotypes in district Mardan. Virol J 2013, 10: 90. 10.1186/1743-422X-10-90PubMedPubMedCentralCrossRef
33.
go back to reference Inamullah , Idrees M, Ahmed H, Sajid u g, Ali M, Ali L, Ahmed A: Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan. Virol J 2011, 8: 16. 10.1186/1743-422X-8-16PubMedPubMedCentralCrossRef Inamullah , Idrees M, Ahmed H, Sajid u g, Ali M, Ali L, Ahmed A: Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan. Virol J 2011, 8: 16. 10.1186/1743-422X-8-16PubMedPubMedCentralCrossRef
34.
go back to reference Masood Z, Jawaid M, Khan RA, Rehman S: Screening for hepatitis B & C: a routine pre-operative investigation. Pak J Med Sci 2005, 21: 455-459. Masood Z, Jawaid M, Khan RA, Rehman S: Screening for hepatitis B & C: a routine pre-operative investigation. Pak J Med Sci 2005, 21: 455-459.
35.
go back to reference Petrelli E, Manzin A, Paolucci S, Cioppi A, Brugia M, Muretto P, Clementi M: Chronic liver disease and active hepatitis C virus infection in patients with antibodies to this virus. J Clin Pathol 1994, 47: 148-151. 10.1136/jcp.47.2.148PubMedPubMedCentralCrossRef Petrelli E, Manzin A, Paolucci S, Cioppi A, Brugia M, Muretto P, Clementi M: Chronic liver disease and active hepatitis C virus infection in patients with antibodies to this virus. J Clin Pathol 1994, 47: 148-151. 10.1136/jcp.47.2.148PubMedPubMedCentralCrossRef
36.
go back to reference Ahmad N, Asgher M, Shafique M, Qureshi JA: An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan. Saudi Med J 2007, 28: 390-395.PubMed Ahmad N, Asgher M, Shafique M, Qureshi JA: An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan. Saudi Med J 2007, 28: 390-395.PubMed
Metadata
Title
Prevalence of active hepatitis C virus infections among general public of Lahore, Pakistan
Authors
Muhammad Ikram Anwar
Moazur Rahman
Mahmood Ul Hassan
Mazhar Iqbal
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2013
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-10-351

Other articles of this Issue 1/2013

Virology Journal 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.